Summary (tl;dr)

Aurobindo Pharma USA Inc. has initiated a voluntary nationwide recall of over 112,000 bottles of Amazon-branded Extra Strength Acetaminophen (500mg caplets) due to consumer complaints of discolored tablets.

Essential Background

Acetaminophen, commonly known as paracetamol, is a widely used over-the-counter medication for pain relief and fever reduction. In May 2025, Aurobindo Pharma USA Inc. previously recalled over 4,000 bottles of Amazon Basic Care Acetaminophen (325mg) for similar discoloration issues, which the FDA classified as a Class II recall, meaning it could cause temporary or medically reversible adverse health consequences with a remote probability of serious effects.

The Full Story

Aurobindo Pharma USA Inc. launched a voluntary recall on September 18, 2026, for 112,932 bottles of Amazon-brand Extra Strength Acetaminophen 500 mg caplets across the United States. This recall affects 200-count, 500-count, and 1,000-count bottles and was prompted by numerous consumer complaints regarding discolored tablets. The affected medication was manufactured in India and distributed by Amazon.com Services LLC. As of the current reports, the U.S. Food and Drug Administration (FDA) has not yet assigned a health-risk classification to this specific recall, though the issue represents a deviation from current good manufacturing practices (cGMP).

Why It Matters

This recall is significant as it involves a popular over-the-counter medication widely used by consumers for common ailments. The presence of discolored tablets raises concerns about the quality and integrity of the product, potentially impacting consumer trust in Amazon-branded medications and the manufacturer, Aurobindo Pharma. Although no immediate health hazards have been identified for this particular recall, the FDA's eventual classification will determine the potential health risks to consumers. This event underscores the importance of stringent manufacturing practices and quality control in the pharmaceutical industry to ensure patient safety.

Geographic Location

• East Windsor, Mercer County, New Jersey, United States (location of Aurobindo Pharma USA Inc., initiating the recall)
• Seattle, King County, Washington, United States (location of Amazon.com Services LLC, distributing the recalled product)
• Telangana, India (potential manufacturing location for the acetaminophen caplets)
• United States (nationwide distribution and recall of affected products)